ArticleJACC. Advances2026
Frailty Status Predicts Adverse Outcomes in Ambulatory Heart Failure With Preserved Ejection Fraction.
Article in JACC. Advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prognostic Role of Immunonutritional Indices in Elderly Patients with HFpEF: Long-Term Follow-Up of the CONUT, PNI, and CALLy Scores.Journal of clinical medicine · 2026Article
- Fried Frailty Phenotype and 6-Month Risk of First All-Cause Rehospitalisation Among Older Outpatients with Heart Failure and LVEF >40%: A Multicentre Prospective Cohort Study.International journal of general medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundFrailty reflects multisystem physiologic dysfunction and is linked to adverse outcomes. Its prevalence and prognostic importance in ambulatory heart failure with preserved ejection fraction (HFpEF) are unclear.
objectivesThe purpose of this study was to define clinical, hemodynamic, and biological correlates of frailty in HFpEF and its association with outcomes.
methodsAmbulatory HFpEF patients referred to the Johns Hopkins HFpEF Clinic frailty assessment defined by the five-component Physical Frailty Phenotype score (0-5) along with clinical, laboratory and echocardiographic assessment. Subsets of patients underwent pulmonary function testing, right heart catheterization and research endomyocardial biopsy. The primary outcome was HF-related hospitalization or death through 3 years.
resultsAmong 184 patients (age 65 ± 11 years; 66% women), 75 (41%) were frail. Compared with nonfrail/prefrail patients, frail patients had worse functional class, higher N-terminal pro B-type natriuretic peptide, higher ferritin, lower hemoglobin, higher pulmonary capillary wedge pressure (PCWP), and greater endomyocardial biopsy inflammatory infiltrate. Age and PCWP correlated with higher frailty scores. Over 3 years, 87 composite events occurred. Frailty was associated with a higher risk of the primary outcomes (HR: 1.60; 95% CI: 1.05-2.44; P = 0.028; HR for men 2.49; 95% CI: 1.15-5.39; HR for women 1.32; 95% CI: 0.79-2.19). Associations remained significant after adjusting for age, body mass index, and comorbidities, but attenuated after adjusting for PCWP (HR: 1.58; 95% CI: 0.92-2.72; P = 0.100) or hemoglobin and ferritin (HR: 1.08; 95% CI: 0.65-1.78; P = 0.763).
conclusionsFrailty is common in ambulatory HFpEF. In unadjusted models, frailty is associated with higher risk, but this is attenuated after accounting for congestion and anemia/iron markers, supporting a shared pathophysiologic pathway linking frailty and HFpEF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.